Abbott gets FDA authorization for new COVID-19 antibody test

The AdviseDx test can find a COVID-19 antibody called Immunoglobulin M, an indication of more recent infection because the antibody is undetected weeks or months after infection..

” Abbott has actually established tests to discover the virus at each stage of infection, so physicians and their clients are equipped with knowledge of how they are reacting to the virus and advancing through healing,” stated Abbott CEO Robert Ford.

Read the complete press release here.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by clicking here.

Maia Anderson –
Tuesday, October 13th, 2020

The lab-based test can assist clients determine where they remain in their healing from the infection and help suppliers identify whether treatment, follow-up or isolation consultations are required, Abbott stated..

More articles on supply chain: Healthcare labor unions take legal action against United States over alleged failure to supply PPE to vital workersFDA cautions Battelle about mask sanitation systemHow Baptist Health South Florida has actually prevented running out of PPE.

Abbott said Oct. 12 it has actually gotten emergency situation authorization from the FDA for a brand-new antibody test that is designed to discover more current infections..

The test demonstrated 99.56 percent uniqueness, so its not likely to find false negatives, as well as 95 percent level of sensitivity, implying theres a 5 percent chance it will give a false positive result..